期刊文献+

2型糖尿病并发脂肪肝的临床研究 被引量:5

A clinic study of fatty liver in patients with type 2 diabetes mellitus
下载PDF
导出
摘要 目的探讨2型糖尿病合并脂肪肝的主要危险因素。方法采用病例对照研究的方法观察338例2型糖尿病并发脂肪肝和无脂肪肝患者的年龄、身高、体重、腰围、臀围、体重指数(BMI)、腰臀比、空腹血糖(FBG)、C肽、糖化血红蛋白(HbAlc)、谷草转氨酶(AST)、谷丙转氨酶(ALT)、总胆红素(TBIL)、直接胆红素(DBIL)、碱性磷酸酶(ALP)、γ-谷氨酰转肽酶(γ-GT)、肌酐、甘油三酯(TG)、总胆固醇(TC)、高密度脂蛋白(HDL)、低密度脂蛋白(LDL)、2 h血糖、2 h C肽等指标:多因素相关分析采用Logistic逐步回归。结果2型糖尿病并发脂肪肝组与无脂肪肝组年龄、身高、FBG、2 h血糖、HbAlc、TBIL、DBIL、ALP、肌酐、TC、LDL无显著性差异(P>0.05),体重、BMI、腰围、臀围、腰臀比、空腹C肽、2hC肽、AST、ALT、γ-GT、TG、HDL有显著性差异(P<0.01);BMI(OR=1.22)、空腹C肽(OR=2.24)与2型糖尿病并发脂肪肝呈正相关,HDL(OR=0.26)与2型糖尿病并发脂肪肝呈负相关。结论肥胖、胰岛素抵抗及脂质代谢紊乱是2型糖尿病并发脂肪肝的主要危险因素。 Objective To explore the risk factors associated with fatty liver in patients with type 2 diabetes mellitus. Methods Compared the serum concentration of fasting blood glucose (FBG) , C-P, HbAlc, AST, ALT, TBIL, DBIL, ALP, γ-GT, Cr, TG, TC,HDL, LDL, 2h BG, 2h C-P and age, stature, weight, body mass index (BMI) , waist circumference, hip ,circumference and wais-thip ratio (WHR) in 338 type 2 diabetic patients with or without fatty liver. The associated variables were analyzed by using logistic regression model. Results There were not differences in the concentration of FBG, 2h BG, HbAlc, TBIL, DBIL, ALP, Ct, TC, LDL and age, stature between with and without fatty liver in T2DM. There were obvious difference in the concentration of C-P, 2h C-P, AST. ALT,γ-GT, TG,HDL and weight, BMI, waist circumference, hip circumference, WHR between with and without fatty liver in T2DM. BMI (OR: 1.22) and C-P (OR: 2.24) were positive correlated to fatty liver in the patients with type 2 diabetes. In contrast, HDL (OR: 0.26) was negative correlated to it. Conclusion Obesity, insulin resistance and dyslipidemia are the chief risk factors of fatty liver in patients with type 2 diabetes mellitus.
出处 《胃肠病学和肝病学杂志》 CAS 2007年第2期171-173,共3页 Chinese Journal of Gastroenterology and Hepatology
关键词 2型糖尿病 脂肪肝 胰岛素抵抗 Type 2 diabetes mellitus Fatty liver Insulin resistance
  • 相关文献

参考文献12

  • 1Sheth SG,Gordon FD, Chopra S. Nonalcoholic steatohepatitis[ J ]. Ann Intern Med, 1997,126 (2) : 137-145.
  • 2Cortez-Pinto H, Chatham J, Chacko VP, et al. Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: a pilot study [J]. JAMA, 1999,282(17): 1659-1664.
  • 3Kelley DE, MeKolanis TM, Hegazi RA, et al. Fatty liver in type 2 diabetes mellitus: relation to regional adiposity, fatty acids, and insulin resistance[J]. Am J Physiol Endoerinol Metab, 2003,285(4) : E906- E916.
  • 4Pares A, Tresserras R, Nunez I, et al. Prevalence and factors associated to the presence of fatty liver in apparently healthy adult men [ J ]. Med Clin (Bare) ,2000,114( 15 ) :561-565.
  • 5陈明卫,杨明功,王佑民,王长江,潘天荣,胡红琳,孙海燕.2型糖尿病合并脂肪肝的危险因素分析[J].临床肝胆病杂志,2004,20(1):44-45. 被引量:14
  • 6Kawasaki T, Hashimoto N, Kikuehi T, et al. The relationship between fatty liver and hyperinsulinemia in obese Japanese children[ J]. J Pediatr Gastroenterol Nutr, 1997,24(3) :317-321.
  • 7Sanyal AJ. AGA technical review on nonalcoholic fatty liver disease [J]. Gastroenterology, 2002,123(5) : 1705-1725.
  • 8Bugianesi E, Manzini P, D'Antico S, et al. Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver[J]. Hepatology, 2004,39(1 ) : 179-187.
  • 9Marehesini G, Brizi M, Morselli-Labate AM, et al. Association of nonalcoholic fatty liver disease with insulin-resistance [ J]. Am J Med, 1999,107 (5) :450-455.
  • 10WANG LiDong1, ZHOU Qi1, WEI JunPing1, YANG WanCai1, ZHAO Xin1, WANG LiXia1, ZOU Jian Xiang1, GAO ShanShan1, LI YongXin1 and YANG C.S.2Keywords esophageal neoplasms,apoptosis,precancerous lesions,Waf1 p21 gene,p53.Apoptosis and its relationship with cell proliferation,p53,Waf1p21,bcl-2 and c-mycin esophageal carcinogenesis studied with a high-risk population in northern China[J].World Journal of Gastroenterology,1998,4(4):15-21. 被引量:302

二级参考文献9

  • 1[1]Bacon BR, Farahvash MJ, Janney CG, et al. Nonalcoholic steatohepatitis:an expanded clinical entity[J]. Gastroenterology, 1994, 107:1103 -1109.
  • 2[2]Sheth SG, Gordon FD, Chopra S. Nonalcoholic steatoheptitis[J]. Ann Intern Med, 1997,126(2):137- 145.
  • 3[3]Matthews DR, Hosker JP, Rudenski AS, et al. Homeestasis model assessment:insulin resistance and beta- cell function from fasting plasma glucose and insulin concentrations in man[J]. Diabetologia, 1985,28(7)- 419.
  • 4[4]Paul A. Nonalcoholic fatty liver disease[J].N Engl J Med, 2002, 346(16): 1221 - 1231.
  • 5[5]Cortes PH, Camilo ME, Baptista A, et al. Nonalcoholic fatty liver:another feature of the metabolic syndrome [J].Clin Nutr, 1999,18:353- 358.
  • 6[6]Kumar KS, Malet PF. Nonalcoholic steatohepatitis[J] .Mayo Clin Proc,2000,75(7) :733 - 739.
  • 7[7]Marchesini G, Brizi M, Morselli- Labate AM, et al. Association of nonalcoholic fatty liver disease with insulin resistance[J] .Am J Med, 1999,107(5) :450-455.
  • 8[8]Luyckx FH, Lefebvre PJ, Scheen AJ. Nonalcoholic steatohepatitis: association with obesity and insulin resistance, and influence of weight loss[J].Diabetes Metab, 2000,26:98- 106.
  • 9[9]Pares A, Tresserras R, Nunez I, et al. Prevalence and factors associated to the presence of fatty liver in apparently health adult men[J] .Med Clin Barc, 2000,114:561-565.

共引文献314

同被引文献54

引证文献5

二级引证文献101

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部